Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
/PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the...
Stay updated with breaking news from Life Sciences Domain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the...
According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the year 2023. Projections indicate that potential fluctuations could drive the market's value to USD 520 billion...
OneMedNet Expands Leadership Team with Addition of Technology Leader, ...
PHC Holdings Corporation headquarters Minatoku Tokyo Japan President Representative Director and CEO Shoji Miyazaki hereafter PHCHD announces that it has acquired the remaining 30 stake in its subsidiary SciMed Asia Pte. Ltd.
PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) ...